The third Covid-19 vaccine registered in Russia is based on a “perfectly conventional” platform, and those who have been injected experienced no side effects, the head of the Chumakov Scientific Center, which created it, told RT. The CoviVac vaccine received national approval in Russia on February 20. The first batch of doses is expected to be available to the public in mid-March, according to the government. The vaccine is based on the most traditional technology that has been around for a long time and is widely used throughout the world, Aidar Ishmukhametov, the director general of the Chumakov Scientific Center, told RT.
Hence then, the article about russia s 3rd vaccine covivac developer tells rt new jab uses classic dead virus technology was published today ( ) and is available onRussia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Russia’s 3rd vaccine: CoviVac developer tells RT new jab uses classic ‘dead virus’ technology )